Matricelf Ltd (TLV:MTLF)
Israel · Delayed Price · Currency is ILS · Price in ILA 228.70
-2.30 (-1.00%)
Aug 5, 2025, 12:47 PM IDT
bluebird bio Market Cap
Matricelf has a market cap or net worth of 38.11 million as of August 5, 2025. Its market cap has decreased by -33.15% in one year.
Market Cap
38.11M
Enterprise Value
27.43M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$228.70
Market Cap Chart
Since June 20, 2021, Matricelf's market cap has decreased from 62.00M to 38.11M, a decrease of -38.53%. That is a compound annual growth rate of -11.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2025 | 38.70M | -34.68% |
| Dec 31, 2024 | 59.23M | 18.14% |
| Dec 31, 2023 | 50.14M | -7.15% |
| Dec 29, 2022 | 54.00M | -47.98% |
| Dec 30, 2021 | 103.80M | 67.43% |
| Jun 20, 2021 | 62.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 60.25B |
| Danel (Adir Yeoshua) | 2.76B |
| Kamada | 1.46B |
| Bait Bakfar | 1.12B |
| SofWave Medical | 884.68M |
| BrainsWay | 757.07M |
| Novolog (Pharm-Up 1966) | 710.12M |
| Ilex Medical | 675.20M |